Gülçin Gezgin

835 total citations
12 papers, 605 citations indexed

About

Gülçin Gezgin is a scholar working on Ophthalmology, Immunology and Molecular Biology. According to data from OpenAlex, Gülçin Gezgin has authored 12 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Gülçin Gezgin's work include Ocular Oncology and Treatments (11 papers), Immunotherapy and Immune Responses (6 papers) and Corneal Surgery and Treatments (2 papers). Gülçin Gezgin is often cited by papers focused on Ocular Oncology and Treatments (11 papers), Immunotherapy and Immune Responses (6 papers) and Corneal Surgery and Treatments (2 papers). Gülçin Gezgin collaborates with scholars based in Netherlands, United States and Australia. Gülçin Gezgin's co-authors include Martine J. Jager, Pieter A. van der Velden, J. William Harbour, Matthew G. Field, Stefan Kurtenbach, Christina L. Decatur, Gregorius P. M. Luyten, Robert M. Verdijk, Mehmet Doğrusöz and Sjoerd H. van der Burg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Gülçin Gezgin

12 papers receiving 602 citations

Peers

Gülçin Gezgin
Benjamin A. Krantz United States
CarolL Shields United States
Trinh Pham United States
Lesley Everett United States
Enzo Fulco United States
Gülçin Gezgin
Citations per year, relative to Gülçin Gezgin Gülçin Gezgin (= 1×) peers Ann‐Cathrine Larsen

Countries citing papers authored by Gülçin Gezgin

Since Specialization
Citations

This map shows the geographic impact of Gülçin Gezgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülçin Gezgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülçin Gezgin more than expected).

Fields of papers citing papers by Gülçin Gezgin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülçin Gezgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülçin Gezgin. The network helps show where Gülçin Gezgin may publish in the future.

Co-authorship network of co-authors of Gülçin Gezgin

This figure shows the co-authorship network connecting the top 25 collaborators of Gülçin Gezgin. A scholar is included among the top collaborators of Gülçin Gezgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülçin Gezgin. Gülçin Gezgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gelmi, Maria Chiara, Gülçin Gezgin, Pieter A. van der Velden, et al.. (2023). PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 64(15). 36–36. 12 indexed citations
2.
Gezgin, Gülçin, Marten Visser, Dina Ruano, et al.. (2022). Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment. SHILAP Revista de lepidopterología. 2(2). 100132–100132. 14 indexed citations
3.
Wierenga, Annemijn P. A., Gülçin Gezgin, Els van Beelen, et al.. (2019). Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics. Cancers. 11(8). 1202–1202. 16 indexed citations
4.
Brouwer, Niels J., Annemijn P. A. Wierenga, Gülçin Gezgin, et al.. (2019). Ischemia Is Related to Tumour Genetics in Uveal Melanoma. Cancers. 11(7). 1004–1004. 15 indexed citations
5.
Brouwer, Niels J., Gülçin Gezgin, Annemijn P. A. Wierenga, et al.. (2019). Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution. Cancers. 11(7). 979–979. 27 indexed citations
6.
Gezgin, Gülçin, Mehmet Doğrusöz, T. Huibertus van Essen, et al.. (2017). Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment. Cancer Immunology Immunotherapy. 66(7). 903–912. 86 indexed citations
7.
Madigan, Michele C., Marco Versluis, Gülçin Gezgin, et al.. (2017). GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi. British Journal of Cancer. 117(6). 884–887. 65 indexed citations
8.
Gezgin, Gülçin, Jinfeng Cao, Mehmet Doğrusöz, et al.. (2017). PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma. JAMA Ophthalmology. 135(6). 541–541. 86 indexed citations
9.
Field, Matthew G., Christina L. Decatur, Stefan Kurtenbach, et al.. (2016). PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. Clinical Cancer Research. 22(5). 1234–1242. 196 indexed citations
10.
Gezgin, Gülçin, Inge H. G. Bronkhorst, T. Huibertus van Essen, et al.. (2015). Loss of BAP1 expression is associated with increased angiogenesis in uveal melanoma. Investigative Ophthalmology & Visual Science. 56(7). 5323–5323. 1 indexed citations
11.
Asnaghi, Laura, Gülçin Gezgin, James T. Handa, et al.. (2015). EMT-associated factors promote invasive properties of uveal melanoma cells.. PubMed. 21. 919–29. 45 indexed citations
12.
Kooiman, Judith, Gülçin Gezgin, J.P. de Vries, et al.. (2013). Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: Risk comparison adjusted for patient characteristics by design. American Heart Journal. 165(5). 793–799.e1. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026